A method and apparatus for assessing total vascular flow velocity
By combining ultrasonic speckle decorrelation analysis and beamforming technology with autocorrelation analysis and least squares fitting, the accuracy problem of total vascular flow velocity assessment was solved, achieving efficient total vascular flow velocity assessment that does not depend on the detection angle or operator calibration.
Patent Information
- Application Number
- CN202410102671.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-01-24
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2044-01-24
AI Technical Summary
Existing technologies are insufficient to accurately assess total vascular flow velocity, and the assessment results are affected by the detection angle and operator calibration, making it impossible to accurately reproduce the total vascular flow velocity.
An ultrasound speckle decorrelation analysis-based method was adopted. By using a one-dimensional array ultrasound probe and beamforming technology, the ultrasound echo signal was reconstructed. Combined with autocorrelation analysis and least squares fitting, the horizontal and axial velocity components of the blood vessel were calculated, and the total blood vessel velocity was synthesized.
It enables accurate assessment of total blood flow velocity, reduces reliance on detection angle and operator calibration, and lowers system complexity and computational cost.
Smart Images

Figure CN117770873B_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of medical devices and methods, specifically relating to a method for assessing total vascular flow velocity. Background Technology
[0002] With the aging of my country's population and the changing lifestyles of its residents, cardiovascular and cerebrovascular diseases have become one of the major threats to the health of Chinese residents. Early diagnosis and intervention of these diseases, and effectively reducing their mortality rate, have become urgent problems to be solved. Studies have found that before the onset of cardiovascular and cerebrovascular diseases, the hemodynamic parameters (vascular morphology, blood flow velocity, and blood perfusion) of the major arterial network in the human body have already undergone significant changes. This makes it possible to diagnose cardiovascular and cerebrovascular disease attacks by monitoring hemodynamic changes. Ultrasound imaging, with its non-invasive, non-contrast-free, and high spatiotemporal resolution characteristics, and combined with dynamic analysis methods, can also assess important parameters such as blood flow velocity and blood perfusion, and has been widely used in the early screening of microcirculatory diseases. Among these, accurate assessment of total vascular velocity has high practical significance in clinical screening.
[0003] Domestic and international research groups have proposed a series of analytical methods for assessing vascular blood flow velocity, focusing on the dynamic characteristics of blood flow. Traditional color Doppler ultrasound is the "gold standard" for blood flow velocity assessment, accurately evaluating axial velocity by quantifying the spectral shift caused by red blood cell flow. However, this method only measures a one-dimensional component of the total flow velocity, and the measurement results depend on the angle between the ultrasound probe and the target vessel, making it difficult to accurately reveal the total vascular flow velocity. Vector Doppler ultrasound can accurately assess the two-dimensional (axial and lateral) velocity components within the ultrasound probe plane, but it cannot measure the velocity component in the elevation direction (perpendicular to the ultrasound probe plane). Therefore, in practice, specially trained physicians often need to align the ultrasound probe along the long axis of the vessel, a process heavily reliant on physician calibration, resulting in significant uncertainty in the total flow velocity assessment. Ultrasound localization microscopy based on two-dimensional array ultrasound probes and microbubble localization tracking can measure the three-dimensional velocity components of the vessel, thereby further synthesizing the total vascular flow velocity. However, this technology often requires the use of multiple ultrasound imaging platforms, resulting in high operating and computational costs. Summary of the Invention
[0004] (a) Technical problems to be solved
[0005] This invention addresses the problems of existing technologies that can only assess one-dimensional (axial) or two-dimensional (axial and transverse) velocity components of blood vessels, resulting in the inability to accurately reconstruct the total blood flow velocity, and the fact that the assessment effect is affected by the detection angle and operator calibration. It provides a method and device for assessing total blood flow velocity based on ultrasound speckle decorrelation analysis. By selecting an appropriate receiving aperture during beamforming to reconstruct the ultrasound echo signal, and combining this with ultrasound speckle decorrelation analysis theory, it effectively achieves accurate assessment of total blood flow velocity. Simultaneously, it meets the requirements of measuring total blood flow velocity using only a one-dimensional array ultrasound probe and that the assessment results are independent of the detection angle and operator calibration, providing convenience for clinicians to screen for early circulatory system-related diseases.
[0006] (II) Technical Solution
[0007] To address its technical problems, the present invention provides a method and apparatus for assessing total vascular flow velocity, the specific technical solution of which is as follows.
[0008] This invention discloses a method for assessing total vascular flow velocity, characterized by comprising the following steps:
[0009] Step A: Use a one-dimensional array ultrasound probe to emit ultrasonic pulses and receive the echo signal reflected by the sample;
[0010] Step B: Reconstruct the echo signal using beamforming to obtain reconstructed data IQ. The receiving aperture used in beamforming is smaller than the effective receiving aperture of the one-dimensional linear array ultrasonic probe, and the lateral resolution σ of the reconstructed data is optimized. x With elevation direction resolution σ y Satisfying the relation: σ x-y =σ x =σ y The σ x-y To reconstruct the horizontal resolution of the data, the elevation angle direction is perpendicular to the ultrasonic detection surface;
[0011] Step C: Extract the dynamic blood flow signal contained in the reconstructed data IQ, which is sIQ;
[0012] Step D: Perform autocorrelation calculation on the dynamic blood flow signal sIQ to obtain autocorrelation data g with attenuation characteristics. 1,exp (τ), the g 1,exp The amplitude of (τ) is related to both the horizontal velocity component and the axial velocity component of the blood vessel, while the imaginary part is only related to the axial velocity component of the blood vessel.
[0013] Step E: For the autocorrelation data g 1,exp Phase analysis is performed on the imaginary part of (τ) to calculate the axial velocity component V of the blood vessel. z;
[0014] Step F: Calculate the axial velocity component V obtained in step E. z Substitute into the autocorrelation data g 1,exp In (τ), the horizontal velocity component of the blood vessel is the factor affecting g. 1,exp The only unknown quantity of the amplitude (τ) is the horizontal velocity component V of the blood vessel, which is calculated based on the least squares fitting principle. x-y ;
[0015] Step G: Calculate the horizontal surface velocity component V based on step F. x-y The axial velocity component V calculated in step E z The total blood flow velocity V was calculated. total .
[0016] Preferably, in step D, autocorrelation calculation is performed on the dynamic blood flow signal sIQ to obtain autocorrelation data g. 1,exp The formula for calculating (τ) is:
[0017]
[0018] Where * represents complex conjugate, <…> t τ represents the overall time average, and τ is the time delay.
[0019] Preferably, in step E, the autocorrelation data g 1,exp Phase analysis is performed on the imaginary part of (τ) to calculate the axial velocity component V. z The formula is:
[0020]
[0021] Where λ0 is the wavelength of the ultrasonic pulse emitted in step A, and τ c For the autocorrelation data g in step D 1,exp The time corresponding to the first extremum of the imaginary part of (τ).
[0022] Preferably, in step F, the least squares fitting process involves the autocorrelation data theoretical model g. 1,theory (τ), the g 1,theory (τ) is determined by the three-dimensional resolution of the reconstructed data and the three-dimensional flow velocity components of the blood vessels. The three dimensions include three spatial directions: lateral, elevation, and axial. 1,theory The expression for (τ) is:
[0023]
[0024] Where e is the natural exponent, i is the imaginary unit, τ is the time delay, and k0 is the wave number, calculated using the following formula: λ0 is the wavelength of the ultrasonic pulse emitted in step A, σ x , σ y With σ z V represents the lateral, elevation, and axial resolutions of the reconstructed data IQ, respectively. x V y With V z These represent the transverse, elevation, and axial velocity components of the blood vessel, respectively.
[0025] According to step B, the lateral resolution of the reconstructed data IQ is the same as the elevation resolution, i.e.: σ x-y =σ x =σ y ,g 1,theory The functional expression for (τ) can be replaced by:
[0026]
[0027] Where, σ x-y V represents the horizontal plane resolution of the reconstructed data in step B. x-y The magnitude of the combined velocity component of the transverse flow and the velocity component in the elevation direction of the blood vessel is expressed as:
[0028] Preferably, in step F, the horizontal velocity component V of the blood vessel x-y Determined by the fitting factor R, V calculated in step E z With a series of velocity values V x-y,i Substituting into R, where V maximizes R. x-y,i This refers to the horizontal velocity component of the blood vessel, where R is calculated using the following formula:
[0029]
[0030] Among them, g 1,exp (τ) represents the autocorrelation data in step D, g 1,thory (τ) is the autocorrelation data theoretical model, where τ is the time delay, <…> represents the overall time average, and |…| represents taking the absolute value.
[0031] Preferably, in step G, the total flow velocity in the blood vessel is the magnitude of the total flow velocity vector synthesized from the two extracted flow velocity components, calculated by the following formula:
[0032]
[0033] Preferably, this method is applicable not only to the assessment of total flow velocity in blood vessels, but also to the assessment of total flow velocity in other flowing fluids with ultrasound reflectivity.
[0034] The present invention also discloses an apparatus for assessing total vascular flow velocity, which uses the aforementioned method for assessing total vascular flow velocity to assess vascular flow velocity.
[0035] (III) Beneficial Effects
[0036] Compared with the prior art, the present invention has significant positive technical effects, and its beneficial effects are reflected in at least the following aspects.
[0037] (1) This invention employs the ultrasonic speckle decorrelation analysis theory, while existing technologies mostly use the Doppler principle. Doppler-based ultrasonic velocimetry, when using a one-dimensional array ultrasonic probe, can only assess the one-dimensional (axial) or two-dimensional (axial and transverse) velocity components of blood vessels, but cannot assess the velocity component in the elevation direction, thus making it difficult to accurately reconstruct the total velocity of the blood vessel. This invention can directly analyze the horizontal velocity component of the blood vessel (the modulus of the composite of the transverse and elevation velocity components) V. x-y and the axial velocity component V of the blood vessel z This allows for the synthesis of total blood flow velocity, which is more accurate and efficient than existing technologies.
[0038] (2) This invention utilizes the ultrasonic speckle decorrelation analysis theory to achieve accurate assessment of total vascular velocity, and the assessment accuracy is unaffected by the angle between the ultrasonic probe and the target vessel. In contrast, existing technologies often require operators to adjust the ultrasonic probe to a suitable angle to assess blood flow velocity, a process highly dependent on operator calibration. This invention adjusts the lateral resolution of the reconstructed data to be the same as the elevation resolution. Therefore, the autocorrelation function of the same vessel exhibits the same decay rate at different probe angles, making the assessment of total vascular velocity unaffected by the probe angle and effectively reducing the dependence on probe angle and operator calibration during ultrasonic flow velocity assessment.
[0039] (3) This invention can analyze the total vascular flow velocity using a single one-dimensional array ultrasound probe and ultrasound imaging platform; while existing technologies often use two-dimensional array ultrasound probes and multiple ultrasound imaging platforms to evaluate the three-dimensional blood flow velocity components of blood vessels, and then synthesize the total vascular flow velocity. This invention can reduce the complexity of the total vascular flow velocity assessment system and the costs of data acquisition and computation. Attached Figure Description
[0040] Figure 1 This is a flowchart of a method for assessing total vascular flow velocity based on ultrasound speckle decorrelation analysis.
[0041] Figure 2 This is a schematic diagram of spatial orientation (lateral, elevation, and axial directions).
[0042] Figure 3This is a schematic diagram showing the first extremum of the imaginary part of the autocorrelation function of the blood flow signal.
[0043] Figure 4 To calculate the horizontal velocity component V of the blood vessel x-y The curve fitting graph. Detailed Implementation
[0044] To address its technical problems, this invention provides a method and apparatus for assessing total vascular flow velocity. The technical solution of this invention will be further described below with reference to the accompanying drawings and specific embodiments.
[0045] This embodiment proposes a flow velocity assessment method based on ultrasonic speckle decorrelation analysis, which can achieve the assessment of total blood flow velocity in blood vessels without relying on measurement angle or operator calibration. Figure 1 This is a flowchart illustrating a method for assessing total vascular flow velocity provided in an embodiment of this application. The specific implementation steps are as follows:
[0046] Step 1: The Prodigy 256-channel ultrasound research platform drives a one-dimensional array ultrasound probe to transmit pulsed ultrasound signals with a center frequency of 7.5MHz and a repetition frequency of 30kHz. The target sample is continuously probed to obtain 1000 sets of continuous ultrasound echo signals. The center frequency and repetition frequency used in this embodiment are only examples to illustrate the main idea of the present invention. Other pulsed ultrasound signals with different center frequencies and repetition frequencies can be selected according to the actual application scenario.
[0047] Step 2: Perform phase orthogonal demodulation on each group of ultrasonic echo signals using Hilbert transform, and use the delay-superposition algorithm to reconstruct the image of the demodulated signals to obtain 1000 sets of reconstructed data IQ.
[0048] It should be noted that this embodiment selects a receiving aperture of 0.3 for image reconstruction, so that the lateral resolution of the reconstructed data is the same as the elevation resolution (spatial orientation as shown in the figure). Figure 2 As shown), the resolution is 1 mm; therefore, the autocorrelation function of the same blood vessel has the same decay rate at different detection angles, so that the assessment of the total blood vessel flow velocity is not affected by the detection angle; the horizontal plane resolution used in this embodiment is only an example to illustrate the main idea of the present invention, and the required horizontal plane resolution can be determined according to the one-dimensional array ultrasound probe of the actual application.
[0049] Step 3: High-pass filtering was performed on 1000 sets of reconstructed data IQ using a singular value decomposition-based filtering method to extract the dynamic blood flow signal contained therein, and the result is sIQ;
[0050] It should be noted that the main reflector in the vascular region is red blood cells, which move along the blood vessels with the blood, causing the reflected echo signal to exhibit high-frequency fluctuations. However, the echo signal intensity of red blood cells is much lower than that of the tissue region, causing the blood flow signal to be submerged by the low-frequency static tissue signal. Therefore, before performing autocorrelation calculations, it is necessary to use high-pass filtering to suppress the low-frequency tissue signal and extract the high-frequency blood flow signal.
[0051] Step 4: Perform time autocorrelation calculation on 1000 sets of dynamic blood flow signals to obtain autocorrelation data g. 1,exp (τ), the calculation formula is:
[0052]
[0053] Where * represents complex conjugate, <…> t τ represents the overall time average, and τ is the time delay.
[0054] It is important to note that, since the lateral resolution and axial resolution of the reconstructed IQ data are the same, the theoretical model g of the autocorrelation data... 1,theory The expression for (τ) can be written as:
[0055]
[0056] Where e is the natural index, i is the imaginary unit, and k0 is the wave number, calculated using the following formula: λ0 is the wavelength of the ultrasonic pulse emitted in step 1, σ x-y V represents the horizontal plane resolution of the reconstructed data in step 2. x-y Let be the magnitude of the composite of the transverse velocity component and the elevation velocity component of the blood vessel, expressed as:
[0057] Step 5: From the theoretical model g 1,theory The expression (τ) shows that the imaginary part of the autocorrelation data is only related to the axial velocity component in the blood flow velocity; therefore, by analyzing the autocorrelation data g... 1,exp Phase analysis is performed on the imaginary part to obtain the axial velocity component V of the blood vessel. z .
[0058] Preferably, such as Figure 3 As shown, by solving g 1,exp The first extreme time τ of the imaginary part of (τ) c Calculate the axial velocity component V z The specific calculation formula is as follows:
[0059]
[0060] Wherein, λ0 is the wavelength of the ultrasonic pulse emitted in step 1.
[0061] Step 6: Calculate the axial velocity component V from Step 5. z Substituting into the autocorrelation data, the horizontal velocity component V of the blood vessel x-y By using g 1,exp (τ) and theoretical model g 1,theory (τ) is calculated using a nonlinear fitting method, such as Figure 4 As shown.
[0062] Preferably, the horizontal velocity component V of the blood vessel x-y Determined by the fitting factor R, the axial velocity component V z With a series of velocity values V x-y,i Substituting into R, where V maximizes R. x-y,i This refers to the horizontal velocity component of the blood vessel, where R is calculated using the following formula:
[0063]
[0064] Among them, g 1,exp (τ) represents the autocorrelation data from step 4, g 1,theory (τ) is the autocorrelation data theory model.
[0065] τ represents the time delay, <…> represents the overall time average, and |…| represents taking the absolute value.
[0066] Step 7: The total flow velocity in the blood vessel is the magnitude of the total flow velocity vector synthesized from the two extracted velocity components, calculated by the following formula:
[0067]
[0068] The total vascular flow velocity assessment method in this embodiment is based on ultrasound speckle decorrelation analysis. Compared to ultrasound Doppler methods that assess one-dimensional (axial) or two-dimensional (axial and transverse) vascular flow components based on spectral analysis, this method can directly calculate the total vascular flow velocity, offering advantages in both accuracy and efficiency over existing technologies. Furthermore, this embodiment eliminates the need for experienced operators to position the ultrasound probe array at specific angles for accurate assessment of total vascular flow velocity, effectively reducing reliance on operator calibration during ultrasound flow velocity assessment. In addition, the main hardware required for assessing total vascular flow velocity in this embodiment includes only a single one-dimensional linear ultrasound probe and an ultrasound research platform. Compared to methods and devices based on two-dimensional planar ultrasound probe arrays and multiple ultrasound research platforms, the system complexity and imaging cost are significantly reduced, facilitating the widespread adoption of this method.
[0069] The specific embodiments described in this application are merely illustrative examples of the main ideas of the present invention. Those skilled in the art to which this invention pertains may make various modifications or additions to the described specific embodiments or use similar methods to substitute them, without departing from the spirit of the invention or exceeding the scope defined by the appended claims.
Claims
1. A method for total vascular flow rate assessment, characterized by, Includes the following steps: Step A: Use a one-dimensional array ultrasound probe to emit ultrasonic pulses and receive the echo signal reflected by the sample; Step B: Reconstruct the echo signal using beamforming to obtain reconstructed data IQ. The receiving aperture used in the beamforming process is smaller than the effective receiving aperture of the one-dimensional array ultrasound probe, and this ensures that the lateral resolution of the reconstructed data is optimized. Resolution in elevation direction Satisfying the relation: The To reconstruct the horizontal resolution of the data, the elevation angle direction is perpendicular to the ultrasonic detection surface; Step C: Extract the dynamic blood flow signal contained in the reconstructed data IQ, which is sIQ; Step D: Perform autocorrelation calculation on the dynamic blood flow signal sIQ to obtain autocorrelation data with attenuation characteristics. The The amplitude is related to both the horizontal velocity component and the axial velocity component of the blood vessel, while the imaginary part is only related to the axial velocity component of the blood vessel. Step E: For the autocorrelation data Phase analysis is performed on the imaginary part to obtain the axial velocity component of the blood vessel. ; Step F: Calculate the axial velocity component obtained in step E. Substitute into autocorrelation data In the middle, the horizontal velocity component of blood vessels is the factor affecting The only unknown quantity of the amplitude is the horizontal velocity component of the blood vessel, which is calculated based on the least squares fitting principle. ; Step G: Horizontal surface velocity component calculated in step F The axial velocity component calculated in step E The total flow velocity in the blood vessels was calculated. .
2. The method for assessing total vascular flow velocity according to claim 1, characterized in that, In step D, autocorrelation calculation is performed on the dynamic blood flow signal sIQ to obtain autocorrelation data. The calculation formula is: = Where * represents complex conjugate, Represents the overall time average, This is a time delay.
3. The method for assessing total vascular flow velocity according to claim 1, characterized in that, In step E, the autocorrelation data Phase analysis was performed on the imaginary part to calculate the axial velocity component. The formula is: in, The wavelength of the ultrasonic pulse emitted in step A. For the autocorrelation data in step D The time corresponding to the first extreme value of the imaginary part.
4. The method for assessing total vascular flow velocity according to claim 1, characterized in that, In step F, the least squares fitting process involves an autocorrelation data theoretical model. The expression is: in, It is a natural index. It is the imaginary unit. For time delay, It is the wave number, and its calculation formula is: , The wavelength of the ultrasonic pulse emitted in step A. The horizontal plane resolution of the reconstructed data in step B. Let be the magnitude of the composite of the transverse velocity component and the elevation velocity component of the blood vessel, expressed as: .
5. The method for assessing total vascular flow velocity according to claim 1, characterized in that, In step F, the horizontal velocity component of the blood vessel Determined by the fitting factor R, the result calculated in step E is... With a series of speed values Substituting into R, we find the value that maximizes R. This refers to the horizontal velocity component of the blood vessel, where R is calculated using the following formula: in, The autocorrelation data in step D, For autocorrelation data theoretical models, For time delay, Represents the overall time average, This represents taking the absolute value.
6. The method for assessing total vascular flow velocity according to claim 1, characterized in that, In step G, the total flow velocity in the blood vessel is the magnitude of the total flow velocity vector synthesized from the two extracted flow velocity components, calculated by the following formula: 。 7. A device for assessing total vascular flow velocity, characterized in that, It uses a method for assessing total vascular flow velocity as described in any one of claims 1-6 to assess total vascular flow velocity.
